Welcome to our dedicated page for The Chemours news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on The Chemours stock.
The Chemours Company reports developments for a global industrial and specialty chemicals business organized around Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. News commonly covers earnings releases, quarterly dividends, debt financing, and segment demand for products sold under brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™.
Company updates also address refrigerants and thermal-management applications, TiO2 pigment pricing and volume trends, advanced fluoropolymers for semiconductor and electronics markets, and collaborations tied to high-density IT cooling and other specialty-chemistry uses.
The Chemours Company (NYSE: CC) has announced a project to significantly reduce HFC-23 emissions at its Louisville, Kentucky manufacturing site. The initiative includes custom-built technology that aims to capture at least 99% of HFC-23 emissions, a potent greenhouse gas used in critical applications like vaccine refrigeration. This move aligns with Chemours' commitment to environmental responsibility and its 2018 Corporate Responsibility goals, which include reducing fluorinated emissions by 99% and greenhouse gas intensity by 60%. The project is expected to be completed by the end of 2022.
The Chemours Company (NYSE: CC) reported its fourth-quarter and full-year 2020 financial results, revealing net sales of $5.0 billion and net income of $219 million. Despite a challenging year due to COVID-19, the company achieved free cash flow of $540 million and adjusted EBITDA of $879 million for 2020. For Q4, net sales reached $1.3 billion, with an adjusted net income of $103 million. Looking ahead, Chemours projects 2021 adjusted EBITDA between $1.0 and $1.15 billion, indicating a positive outlook for recovery.
The Chemours Company (NYSE: CC) has restructured its former Fluoroproducts segment into two new reportable segments: Thermal & Specialized Solutions and Advanced Performance Materials. This realignment aims to enhance customer focus and improve decision-making. New leadership has been appointed to both segments, effective March 1, 2021. Alisha Bellezza will lead TSS, and Denise Dignam will head APM, both bringing extensive industry experience. The move is expected to unlock growth opportunities and drive innovation in product offerings.
The Chemours Company (NYSE: CC) has declared a quarterly cash dividend of $0.25 per share, payable on March 15, 2021, to stockholders of record by February 26, 2021. This decision reflects Chemours' commitment to returning value to its shareholders while maintaining strong market positions in Titanium Technologies, Fluoroproducts, and Chemical Solutions. The company continues to serve a diverse range of industries with its innovative products and solutions, indicating a stable operational outlook despite market challenges.
DuPont, Corteva, and Chemours have reached a binding agreement to settle disputes related to Chemours' 2015 spin-off. This includes a cost-sharing arrangement for PFAS liabilities and an escrow account totaling $1 billion over eight years. DuPont and Corteva will split costs up to $2 billion, with Chemours contributing additional funds. The companies will also resolve PFOA litigation in Ohio for $83 million, with contributions from each firm. The agreement aims to provide security for shareholders against future environmental claims.
The Chemours Company (NYSE: CC) will announce its fourth quarter 2020 financial results after market close on February 11, 2021. A webcast conference call is scheduled for February 12, 2021, at 8:30 a.m. EST, which will be open to the public. This event offers stakeholders an opportunity to gain insights into Chemours' financial performance and future outlook. Chemours specializes in products essential for various industries including those in Fluoroproducts, Titanium Technologies, and Chemical Solutions.
The Chemours Company (NYSE: CC) commended Congress for passing the bipartisan American Innovation and Manufacturing Act (AIM Act), signed into law on December 27, 2020. The AIM Act is projected to provide $38 billion in economic benefits by 2027 and phase down hydrofluorocarbons (HFCs) across various industries. Chemours has developed low global warming potential (GWP) products and estimates that by 2025, its solutions will eliminate 325 million tons of CO2 equivalents. The company is prepared to support the transition to sustainable alternatives in the U.S. and globally.
The Chemours Company (NYSE: CC) has completed a private offering of $800 million in 5.750% senior unsecured notes due 2028. The proceeds will be used to repurchase existing 6.625% senior notes due 2023 and cover accrued interest. The offering was exempt from registration under the Securities Act, targeting qualified institutional buyers and non-U.S. persons. Chemours maintains a strong market presence in Titanium Technologies, Fluoroproducts, and Chemical Solutions, servicing over 3,700 customers worldwide.
The Chemours Company (NYSE: CC) announced the early tender results for its cash tender offer to purchase outstanding 6.625% senior notes due 2023, with valid tenders amounting to $781.35 million (86.06% of total notes). The early tender deadline was on November 25, 2020, and Chemours received requisite consents to amend the indenture governing the notes. The tender offer expires on December 10, 2020, and includes a total consideration of $1,017.94 per $1,000 principal amount for early tenders. The company expects early settlement on November 27, 2020.
The Chemours Company (NYSE: CC) announced the pricing of an $800 million private offering of 5.750% senior unsecured notes due 2028. The offering, exempt from registration under the Securities Act, will close around November 27, 2020. Proceeds will be used for the purchase and interest of Chemours' existing 6.625% senior notes due 2023 through a cash tender offer. This offering reflects Chemours' commitment to managing its debt and optimizing its capital structure.